Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
ReviewThe role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin—one single nature
Introduction
At one end of a H+-concentration spectrum (high pH or alkaline limiting zone), the induction and/or maintenance of an abnormally high intracellular alkalinization has been repeatedly implicated as playing an essential, direct and pivotal role both in neoplastic transformation as well as in the active maintenance and progression of the neoplastic process [2], [3], [4], [5], [6] (Fig. 1). These different sets of data have recently led various authors to suggest that one of the hallmark characteristics of cancer cells of many different tissues and genetic origins may be the systematic loss of the rigid control of pHi in both the acute and in the chronic situation [2], [4], [7]. Independent of genetic variability, cellular pathological alkalosis, together with an abnormally high glycolytic metabolism that has been recognized since the time of Otto Warburg, are two of the principal factors characterizing cancer cells and malignant tumors in general [2], [4], [8], [9], [10], [11], [12], [13]. Indeed, the high glycolytic rate of tumors, which can be correlated with the degree of malignancy in many tumor types, is taken advantage of in some of the most modern diagnostic techniques used to detect the presence of malignant tumors and their metastases: positron emission tomography (PET) [10], [14], [15], [16]. Such a systemic abnormality of cellular acid–base homeostasis also plays a key role in the transduction of intracellular signals of a wide array of growth factors, a feature often, but not always, mediated by stimulation of the plasma membrane Na+/H+ antiporter isoform 1, also known as the Na+/H+ exchanger isoform 1 (NHE1). This electroneutral transporter expels hydrogen ions out of the cell while interchanging them for Na+ and thereby increasing intracellular Na+ and alkalinizing intracellular pH (pHi). In normal cells, the NHE1 is quiescent at the steady state resting pHi. and is activated only upon cytosolic acidification [6], [7], [17], [18]. In transformed and cancer cells, the NHE1 is hyperactive even at resting pH and the resulting change in cellular alkalinity has been shown to be directly related in most cases to the permanent and uncontrolled proliferation characteristic of neoplastic cells [4], [19], [20], [21], [22]. Recently, compelling evidence has come to light indicating that the activity of the NHE1 is also a critical factor in the activation of proliferation, motility and invasion of cancer cells derived from various tissues [4], [22], [23], [24], [25], [26], [27], [28].
On the other side of the coin, there currently appears to be a dead-lock in the present state of cancer chemotherapy [29]. This seems to be related to the fact that most of the antitumor agents used in the clinical situation are based upon the old “anti DNA” paradigm which during the last 60 years has attempted to induce an antitumor effect by targeting DNA synthesis or cell division and proliferation. It has been recently proposed that the modest progress achieved and the lack of selectivity of current antitumor agents suggests that the “anti DNA” framework is either wrong or at least too simplistic and conceptually poor from the very beginning for such a complex disease [29], [30]. Some of these authors have proposed that the limitations of the present-day approaches can be responsible for the fact that some therapies can even exacerbate the original malignant phenotype, induce escape from apoptosis and negatively affect the progression of the disease [30], [31], [32]. Recently, a new therapeutic perspective is developing which targets cell membrane or signal transduction proteins instead of DNA synthesis. This change is taking place after an increasing bulk of evidence has led researchers to try to trigger mechanisms to induce selective cancer cell death by apoptosis. This relatively new approach is changing the old and aggressive concept of going for “a direct kill of cancer cells” for a more benevolent “help or induce to die” concept. In an attempt to bring together both paradigms, the failure of tumor cells to die following chemotherapeutic treatment appears to be mostly dependent on their resistance to engaging in the apoptotic process [29].
In summary, the purpose of this review is an attempt to analyze and then synthesize the seminal and emerging data in these areas in order to: (i) to interpret the neoplastic process from the point of view of the critical mechanistic level in order to draw basic research and clinical therapeutics nearer to each other; (ii) unite both therapeutic paradigms into a single and more comprehensive one; and (iii) open new directions in cancer prevention and treatment.
Section snippets
Intracellular pH (pHi) and extracellular pH (pHe) in tumors: interrelationships and physiopathological significance
From the beginning of biochemical cancer research decades ago and until today, the relationships between intracellular pH (pHi) and extracellular (pHe) within a tumor have been a highly controversial issue and an unending source of confusion [33], [34]. For many decades, tumor cells were thought to be have an acidic pHi [16], [33]. However, in the last few years, it has been repeatedly shown that cancer cells show a strong tendency towards an alkaline deviation of the entire acid–base
The other side of the coin: regression and treatment
At the other end of an H+-concentration spectrum (low pH, or acid limiting zone), it becomes necessary to analyze which factors and/or mediating mechanisms may lead the entire homeostasis of cell physiology towards a “therapeutic” acidification in the cancer setting. A great deal of experimental evidence coming from modern biochemistry and molecular biology backs up this etiological approach to treatment whose importance is rapidly growing in the context of cancer treatment and innovative
Implications and conclusions. New strategies designed to induce selective apoptosis and overcome resistance to cytotoxic agents
From infectious to neoplastic disease, an etiological and/or unifying approach to the treatment of any disease process should always be sought after (the root approach). In the case of cancer research, this perspective was aimed at uniting under the same view such diverse aspects of oncology ranging from “etiology” to therapeutics. On both sides of this continuum, the highly significant role first of a high pHi in the origin, development and maintenance of the neoplastic state and, secondly,
Acknowledgements
This work was supported by grants of the Castresana Foundation, Vitoria, Spain, PSO CNR-MIUR Grant CU03.00304, FIRB Grant RBAU01B3A3-001 and the Center of Excellence in Biomedical and Agrarian Genomics (CEGBA) of the University of Bari, Italy. We thank Dr. Miriam L. Wahl and Dr. Ignacio Gil Bazo for bibliographic assistance. Moreover, the authors apologize to all investigators who have significantly contributed to the different fields of cancer research studied in this contribution, but whose
References (300)
- et al.
Hallmarks of cancer
Cell
(2000) - et al.
Mathematical modelling of tumor acidity: regulation of intracellular pH
J. Theor. Biol.
(1999) - et al.
Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role of cellular proliferation
Biochem. Biophys. Acta
(1989) - et al.
Intracellular pH regulation in Hep G2 cells: effects of epidermal growth factor, transforming growth factor-α, and insulin growth factor-II on Na+/H+ exchange activity
Hepatology
(1995) - et al.
Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+/H+ exchanger
Blood
(2000) - et al.
Na/H exchange-dependent increase in intracellular pH times G2/M entry and transition
J. Biol. Chem.
(2003) - et al.
CD44 interaction with Na+–H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion
J. Biol. Chem.
(2004) Unified theory on the basic mechanism of normal control and oncogenesis
J. Theor. Biol.
(1971)Effects of duodenal contents on the gastric mucosa under experimental conditions
Lancet
(1964)- et al.
Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy
Lancet
(1986)
BCL-2 and MCL-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine
Exp. Cell Res.
Na+:H+ exchange inhibition induces intracellular acidosis and differentially impairs cell growth and viability of human and rat hepatocarcinoma cells
Toxicol. Lett.
Cellular pH regulators: potentially promising molecular targets of cancer chemotherapy
Cancer Treat. Rev.
LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of action of BCG therapy
J. Urol.
Mechanism of chemical carcinogenesis: an alternative hypothesis
Med. Hypotheses
Carcinogenesis and the plasma membrane
Med. Hypotheses
Hydrogen ion-dependent oncogenesis and parallel new avenues to cancer prevention and treatment using a H+-mediated unifying approach: pH-related and pH-unrelated mechanisms
Crit. Rev. Oncog.
Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump
Nature
Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes
FASEB J.
A novel mechanism of tumorogenesis involving pH-dependent destabilization of a mutant p53 tetramer
Nat. Struct. Biol.
The growth factor activatable Na+/H+ exchange system: a genetic approach
Lower electrical membrane and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein
Biochemistry
On the origin of cancer cells
Science
On respiratory impairment in cancer cells
Science
‘The metabolism of tumors’: 70 years later
pHi, aerobic glycolysis and vascular endothelial growth factor in tumor growth
Why do cancers have high aerobic glycolysis?
Nat. Rev., Cancer
The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models
Cancer Res.
Combined vascular and extracellular pH imaging of solid tumors
NMR Biomed.
Introduction
Na+/H+ exchange and cytoplasmatic pH in the action of growth factors in human fibroblasts
Nature
Amiloride, protein synthesis, and activation of quiescent cells
J. Cell. Physiol.
Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration
Int. J. Cancer
Polarization of Na+/H+ and Cl−/HCO3−exchangers in migrating renal epithelial cells
J. Gen. Physiol.
Ion transport proteins anchor and regulate the cytoskeleton
Curr. Opin. Cell Biol.
Regulation of the formation of tumor cell pseudopodia by the Na(+)/H(+) exchanger NHE1
J. Cell Sci.
The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions
Annu. Rev. Pharmacol. Toxicol.
Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (Edelfosine), a proapoptotic agent in tumor cells
Curr. Drug Metab.
The physiological environment in cancer vascularization, invasion and metastasis
Vacuolar H+-ATPase: functional mechanisms and potential as a target for cancer chemotherapy
Anti-cancer Drugs
Genomic instability in cancer
Tumor pH
Intra- and extracellular pH in solid tumors
Interaction of intracellular pH and cell membrane potential
Association between membrane potential and breast cancer
Tumor Biol.
Cell surface charge and metastasis formation
Acta Pathol. Microbiol. Scand.
Cellular potentials of normal and cancerous fibroblasts and hepatocytes
Cancer Res.
Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth
Am. J. Physiol.: Gastrointest. Liver Physiol.
Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil
J. Natl. Cancer Inst.
pH and multidrug resistance
Cited by (211)
Targeting endothelial permeability in the EPR effect
2023, Journal of Controlled ReleaseOral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil® via neutralizing the acidic tumor microenvironment
2022, Journal of Controlled ReleaseNetwork biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
2022, Drug Resistance UpdatesStructural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation
2020, Journal of Biological Chemistry